Targeting Pim kinases in hematological cancers: molecular and clinical review

M Bellon, C Nicot - Molecular Cancer, 2023 - Springer
Decades of research has recognized a solid role for Pim kinases in lymphoproliferative
disorders. Often up-regulated following JAK/STAT and tyrosine kinase receptor signaling …

KSHV/HHV8-mediated hematologic diseases

E Cesarman, A Chadburn… - Blood, The Journal of …, 2022 - ashpublications.org
Kaposi sarcoma (KS) herpesvirus (KSHV), also known as human herpesvirus 8, is the
causal agent of KS but is also pathogenetically related to several lymphoproliferative …

[HTML][HTML] Rho GTPases in cancer cell biology

FM Vega, AJ Ridley - FEBS letters, 2008 - Elsevier
Rho GTPases contribute to multiple cellular processes that could affect cancer progression,
including cytoskeletal dynamics, cell cycle progression, transcriptional regulation, cell …

[HTML][HTML] PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers

L Brault, C Gasser, F Bracher, K Huber, S Knapp… - …, 2010 - ncbi.nlm.nih.gov
The identification as cooperating targets of Proviral Integrations of Moloney virus in murine
lymphomas suggested early on that PIM serine/threonine kinases play an important role in …

Evolution of the immunoglobulin heavy chain class switch recombination mechanism

J Chaudhuri, U Basu, A Zarrin, C Yan, S Franco… - Advances in …, 2007 - Elsevier
To mount an optimum immune response, mature B lymphocytes can change the class of
expressed antibody from IgM to IgG, IgA, or IgE through a recombination/deletion process …

A library of gene expression signatures to illuminate normal and pathological lymphoid biology

AL Shaffer, G Wright, L Yang, J Powell… - Immunological …, 2006 - Wiley Online Library
Genomics has provided a lever to pry open lymphoid cells and examine their regulatory
biology. The large body of available gene expression data has also allowed us to define the …

Diagnosis and management of lymphomas and other cancers in HIV-infected patients

A Carbone, E Vaccher, A Gloghini… - Nature reviews Clinical …, 2014 - nature.com
Despite the introduction of highly active antiretroviral therapy or combination antiretroviral
therapy (HAART and cART, respectively) patients infected with HIV might develop certain …

Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases

P Aspenström, A Ruusala, D Pacholsky - Experimental cell research, 2007 - Elsevier
The Rho GTPases are influential regulators of signalling pathways that control vital cellular
processes such as cytoskeletal dynamics, gene transcription, cell cycle progression and cell …

Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation

M Montesinos-Rongen, D Van Roost, C Schaller… - Blood, 2004 - ashpublications.org
We have addressed whether aberrant ongoing hypermutation can be detected in the proto-
oncogenes PIM1, c-MYC, RhoH/TTF, PAX5, and the tumor-suppressor gene CD95 in …

Expression of the AID protein in normal and neoplastic B cells

L Pasqualucci, R Guglielmino, J Houldsworth, J Mohr… - Blood, 2004 - ashpublications.org
Somatic hypermutation (SHM) targets primarily the immunoglobulin variable region (IgV)
genes in germinal center (GC) B cells, thereby allowing antibody affinity maturation. A …